|
|
 Deficiency Information - October 13, 2008
| Giving your infants too much iron which they do not need may delay their development, a study has found. The study, led by Dr. Betsy Lozoff, University of Michigan research professor at the Centre for Human Growth and Development, leads a debate on the desirable level of iron supplements | | Wal-Mart rolled out on Monday its 90-day special offer to American consumers that sells medicine for $10. The promo includes marked down prices for women's medication and more price cuts on over 1,000 over-the-counter pharmaceuticals. The $10 drugs cover 350 generic medicines for 90-day prescriptions at Wal-Mart, Neighborhood Market and Sam's Club drugstores across the U.S., except in North Dakota where Wal-Mart has no in-store drugstores. The women's drugs, including treatments for breast cancer and hormone deficiency, are sold at $9. Meanwhile, prices for over 1,000 over-the-counter medication are lowered to $4 or less | | Help for chronic dry eye could be as easy as eye drops. A Massachusetts researcher told AHN Media he thinks he has found an effective treatment for dry eye syndrome (DES). M. Reza Dana, M.D., M.P.H., M.Sc., Director of Cornea and Refractive Surgery Services at the Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service and colleagues at Schepens Eye Research Institute conducted a study using topical eye drop applications to relieve symptoms of DES | | A drug used in treating Parkinson's may also be used against cancer, according to scientists. Dopamine is an artificial version of a chemical neurotransmitter allowing messages to pass between motor neurons in the brain. Patients with Parkinson's disease have loss this chemical neurotransmitter that led to typical symptoms of muscle rigidity and shaking. Dopamine helps overcome the deficiency | | GlaxoSmithKline PLC announced Friday that it will suspend development of its malaria drug Dacart and is recalling another drug, Lapdap, after it discovered the two drugs can lead to anemia. Tests conducted by GSK and partner Medicines for Malaria Venture reveal both drugs lowered hemoglobin concentration in patients with hereditary enzyme deficiency disorders, which affects 10 to 25 percent of the sub-Saharan population in Africa | |
|
|